Suven Pharmaceuticals informs about press release

26 Dec 2022 Evaluate

Suven Pharmaceuticals has informed that the Board of Directors of the Company have been informed by its Promoter, Jasti Property and Equity Holdings (in its capacity as sole trustee of Jasti Family Trust), that they have executed a Share Purchase Agreement with Berhyanda, a Cyprus based company on December 26, 2022. The company has attached Press Release of the acquirer. This intimation is also being uploaded on the Company’s website at www.suvenpharm.com.

The above information is a part of company’s filings submitted to BSE.

Suven Pharma Share Price

661.70 11.85 (1.82%)
15-May-2024 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.45
Dr. Reddys Lab 5932.95
Cipla 1411.75
Zydus Lifesciences 992.90
Lupin 1633.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.